Compass Therapeutics Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +10.4% | +13.4% | -32.4% | +17.2% | -0.7% | -7.2% | -179.7% | |
| – | +39.5% | +338.9% | +0.3% | +32.3% | +14.8% | +39.9% | -2.2% | |
| – | +120.0% | +335.5% | +1,005.5% | -90.4% | – | – | – | |
| – | -111.8% | – | – | -120.2% | – | – | – | |
| – | -76.9% | -77.3% | +1,379.2% | -86.5% | -85.8% | +46.7% | -43.2% | |
| – | -76.9% | – | -4,757.9% | +8,442.4% | – | +73.5% | -299.5% | |
| – | – | – | +136.3% | -40.8% | -100.0% | – | – | |
| – | -137.5% | +0.0% | +66.7% | -100.0% | – | – | – | |
| – | -99.9% | +128,904.7% | +144.4% | -36.1% | -96.1% | +490.7% | +647.5% | |
| – | -213.7% | – | +346.3% | -212.8% | – | – | -166.7% | |
| – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.